From the Journals

Don’t use cannabis to treat OSA, AASM recommends

Publish date: April 17, 2018

 

FROM THE JOURNAL OF CLINICAL SLEEP MEDICINE


“Synthetic medical cannabis may have differential side effects, with variable efficacy and side effects in the treatment of OSA. Therefore, it is the position of the American Academy of Sleep Medicine that medical cannabis and/or its synthetic extracts should not be used for the treatment of OSA,” Dr. Ramar and his associates wrote.

SOURCE: J Clin Sleep Med. 2018 April;14[4]:679-81.

Pages

Recommended Reading

OSA patients report sleeping better with dronabinol
MDedge Internal Medicine
CPAP adherence linked to reduced readmissions
MDedge Internal Medicine
Poor sleep, suicide risk linked in college students
MDedge Internal Medicine
Insomnia, major depressive episode linked in U.S. soldiers
MDedge Internal Medicine
OSA may provide cardioprotection
MDedge Internal Medicine
Excessive daytime sleepiness linked to increase in Alzheimer’s biomarker
MDedge Internal Medicine
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Internal Medicine
Effectiveness, adherence similar for nasal pillows and standard masks
MDedge Internal Medicine
Different OSA subtypes respond differently to therapy
MDedge Internal Medicine
Disrupted sleep tied to alexithymia
MDedge Internal Medicine